Medical Triage in a Time of Scarce Resources. (XPHI-COVID-2)
Medical Triage in a Time of Scarce Resources: a Randomized Controlled Study.
The XPHI-COVID-2 randomized study aims to investigate the moral choices in a context of scarce resources.
The participants are asked to complete the questionnaire of the Oxford Utilitarianism Scale and are exposed to medical triage dilemmas.
Participants are randomized between a group with reading of ethical guidelines and a group without reading of ethical guidelines, before they are asked to complete the questionnaire and being exposed to triage dilemmas.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
It is hypothesized that recalling ethical values before resolving dilemmas could modify the ability to adopt a utilitarian approach in resolving ethical dilemmas.
To verify this hypothesis, the score on the Impartial Harm subscale of the Oxford Utilitarianism Scale (IH-OUS) will be compared between a group with reading of ethical guidelines and a group without reading of ethical guidelines, before they are asked to complete the questionnaire and being exposed to triage dilemmas.
Number of subjects needed for the phase of study evaluating intensivists, anesthesiologists and emergency physicians : 580 - based on preliminary data, assuming 70% complete response rate of the survey and a standard deviation of 5
Secondary outcomes will be considered :
- Beneficence Harm subscale of the Oxford Utilitarianism Scale (IB-OUS)
- Values prioritized to resolve ethical dilemmas : impartial of benefits, prioritization of the young age, saving life years, saving most lives, equality of treatment, prioritization of the worst off, loyalty duty, principle of non-discrimination, prospective and retrospective instrumental value.
First phase of the study will aim to include first-line caregivers : intensivists, anesthesiologists, emergency physicians.
Other phases of the study will aim to include health care professionals from other categories and non health care professionals.
Subgroup analyses are planned :
- Analysis according to the characteristics of the participant: gender, geographic location, diploma and type of exercise, category of institution to which the participant is attached.
- Analysis according to the degree of knowledge in ethics, the degree of familiarity with ethical recommendations, the degree of familiarity with moral philosophy, the degree of religiosity, whether the participants declare to have taken knowledge or not of recommendations concerning medical triage in a situation of scarce resources.
It is also planned to carry out ancillary studies in parallel with the realization of the study presented here:
- A study including non-physician participants aiming to identify the differences between non-physicians and physicians in terms of ethical values mobilized in medical triage.
- A study including medical students aiming to identify an association between propensity to make utilitarian and choices of the medical specialty.
- A study focused on the Oxford Utilitarianism Scale, integrating the results of the pilot study and the confirmatory study, aiming to identify predictors of responses to the dilemmas proposed within the scale.
- A study evaluating the association between delay in ethical dilemmas resolution and utilitarian choices.
Tipo di studio
Iscrizione (Anticipato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Clément GAKUBA, MD PhD
- Numero di telefono: +33231064736
- Email: gakuba-c@chu-caen.fr
Backup dei contatti dello studio
- Nome: Florian COVA, PhD
- Email: Florian.Cova@unige.ch
Luoghi di studio
-
-
Calvados
-
Caen, Calvados, Francia, 14000
- Reclutamento
- Caen University hospital
-
Contatto:
- Clément GAKUBA, MD
- Numero di telefono: +33231064736
- Email: gakuba-c@chu-caen.fr
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Caregivers
- Noncaregivers from general population
Exclusion Criteria:
- Withdrawal of agreement
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Triplicare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Intervention
The participants have to read ethical guidelines before they are asked to complete the questionnaire of the Oxford Utilitarianism Scale and exposed to medical triage dilemmas.
|
Reading of ethical guidelines.
|
|
Nessun intervento: No intervention
The participants do not have to read ethical guidelines before they are asked to complete the questionnaire of the Oxford Utilitarianism Scale and exposed to medical triage dilemmas.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
IH-OUS score
Lasso di tempo: At the end of the inclusion period
|
Score on the Impartial Harm subscale of the Oxford Utilitarianism Scale (IH-OUS) : minimum value is 4 points and maximum value is 28 points. The higher the value is, the more the participant's choices endorse the principle of causing harm to bring the greater good. |
At the end of the inclusion period
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Utilitarian score
Lasso di tempo: At the end of the inclusion period
|
One point is given for each choice consistent with utilitarian principles when solving triage dilemmas, scaling this score from 0 to 14.
|
At the end of the inclusion period
|
|
IB-OUS score
Lasso di tempo: At the end of the inclusion period
|
Score on the Instrumental Beneficence subscale of the Oxford Utilitarianism Scale (IB-OUS) : minimum value is 5 points and maximum value is 35 points. The higher the value is, the more the participant's choices endorse the impartial maximization of the greater good, even at the cost of personal self-sacrifice. |
At the end of the inclusion period
|
|
Oxford utilitarianism scale
Lasso di tempo: At the end of the inclusion period
|
Bi-dimensional scale of utilitarian thinking associating the impartial harm and the beneficence subscale. The minimum value is 9 points and the maximum value is 63 points. This scale aims to assess the utilitarian tendencies in people who are not philosophy professionals. |
At the end of the inclusion period
|
|
Impartial of benefits
Lasso di tempo: At the end of the inclusion period
|
Principle of impartial assignment of resources used in resolving ethical dilemmas. The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value. |
At the end of the inclusion period
|
|
Prioritization of the young age
Lasso di tempo: At the end of the inclusion period
|
Propensity to prioritize the youngest person in ethical dilemmas.
The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value.
|
At the end of the inclusion period
|
|
Saving life years
Lasso di tempo: At the end of the inclusion period
|
Propensity to save the most life years in resolving ethical dilemmas.
The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value.
|
At the end of the inclusion period
|
|
Saving most lives
Lasso di tempo: At the end of the inclusion period
|
Propensity to save most lives in resolving ethical dilemmas.
The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value.
|
At the end of the inclusion period
|
|
Equality of treatment
Lasso di tempo: At the end of the inclusion period
|
Propensity to treat people equally in ethical dilemmas.
The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value.
|
At the end of the inclusion period
|
|
Prioritization of the worst off
Lasso di tempo: At the end of the inclusion period
|
Propensity to prioritize the worst off in ethical dilemmas.
The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value.
|
At the end of the inclusion period
|
|
Duty of loyalty
Lasso di tempo: At the end of the inclusion period
|
Propensity of the caregiver to feel obliged vis-a-vis the patient The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value.
|
At the end of the inclusion period
|
|
Principle of non-discrimination (based on age, disability, socio-economic characteristics, gender, etc.)
Lasso di tempo: At the end of the inclusion period
|
The non-discrimination principle requires the equal treatment of an individual or group irrespective of their particular characteristics. The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value. |
At the end of the inclusion period
|
|
Prospective instrumental value
Lasso di tempo: At the end of the inclusion period
|
Propensity to promote and reward prospective instrumental value, based on future facts. The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value. |
At the end of the inclusion period
|
|
Retrospective instrumental value
Lasso di tempo: At the end of the inclusion period
|
Propensity to promote and reward retrospective instrumental value, based on past facts. The value will be considered as respected by the majority of participants if more than 50% of respondents make a choice of a patient in accordance with this value. |
At the end of the inclusion period
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Investigatore principale: Clément GAKUBA, MD PhD, University Hospital, Caen
Pubblicazioni e link utili
Pubblicazioni generali
- Emanuel EJ, Persad G, Upshur R, Thome B, Parker M, Glickman A, Zhang C, Boyle C, Smith M, Phillips JP. Fair Allocation of Scarce Medical Resources in the Time of Covid-19. N Engl J Med. 2020 May 21;382(21):2049-2055. doi: 10.1056/NEJMsb2005114. Epub 2020 Mar 23. No abstract available.
- Kahane G, Everett JAC, Earp BD, Caviola L, Faber NS, Crockett MJ, Savulescu J. Beyond sacrificial harm: A two-dimensional model of utilitarian psychology. Psychol Rev. 2018 Mar;125(2):131-164. doi: 10.1037/rev0000093. Epub 2017 Dec 21. Erratum In: Psychol Rev. 2018 Mar;125(2):164.
- Capraro, V., Earp, B.D., & Everett, J.A.C. (2019). Priming intuition disfavors instrumental harm but not impartial beneficence. Journal of Experimental Social Psychology. 83, 142-149. DOI: 10.1016/j.jesp.2019.04.006.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Anticipato)
Completamento dello studio (Anticipato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- 1475 (CSL Behring)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .